Berkeley Lights, Inc.
5858 Horton Street
Suite 320
Emeryville
California
94608
United States
86 articles about Berkeley Lights, Inc.
-
Berkeley Lights to Showcase its Optofluidic Discovery Technology at 2022 Festival of Biologics Conference
3/4/2022
Berkeley Lights, Inc., a leader in digital cell biology, announced its participation at the upcoming Festival of Biologics meeting, being held from March 9-11, 2022, at the Marriott Marquis San Diego.
-
Berkeley Lights Reports Fourth Quarter and Full Year 2021 Financial Results
2/24/2022
Reports full year 2021 revenue of $85.4 million, above pre-announced preliminary range Reiterates 2022 revenue outlook
-
Berkeley Lights to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
2/10/2022
Berkeley Lights, Inc., a leader in digital cell biology, announced that the Company will be reporting financial results for the fourth quarter and full year 2021 before market open on Thursday, February 24, 2022.
-
Berkeley Lights to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
2/9/2022
Berkeley Lights, Inc., a leader in digital cell biology, announced the Company will participate in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held virtually from February 15 - 17, 2022.
-
Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service
1/10/2022
Berkeley Lights, Inc., a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, announced a strategic partnership that will enable faster identification of outbreak sources, reduce incidents of fresh produce contamination and minimize the impact of food borne illness related recalls.
-
Berkeley Lights Announces CEO Transition and Preliminary Full Year 2021 Financial Update
1/5/2022
Berkeley Lights, Inc.,, a leader in digital cell biology, announced that Eric D. Hobbs, Ph.D. will transition from his role as chief executive officer and member of the board of directors to president of the Antibody Therapeutics business line.
-
Berkeley Lights to Participate in the 40th Annual J.P. Morgan Healthcare Conference
1/3/2022
Berkeley Lights, Inc., a leader in digital cell biology, announced the Company will be participating virtually in the upcoming 40th Annual J.P. Morgan Healthcare Conference.
-
Berkeley Lights to Showcase its Optofluidic Discovery Technology at 2021 Antibody Engineering & Therapeutics Conference
12/9/2021
Berkeley Lights, Inc., a leader in digital cell biology, announced its participation at the upcoming Antibody Engineering & Therapeutics meeting, being held virtually and in person from Dec. 12-16, 2021, in San Diego, California.
-
Berkeley Lights to Participate in the Stifel 2021 Virtual Healthcare Conference
11/9/2021
Berkeley Lights, Inc., a leader in digital cell biology, announced the company will be participating in the upcoming Stifel 2021 Virtual Healthcare Conference.
-
Berkeley Lights Reports Third Quarter 2021 Financial Results Record third quarter 2021 revenue grew 34% year over year
11/4/2021
Berkeley Lights, Inc., a leader in Digital Cell Biology, reported financial results for the quarter ended September 30, 2021.
-
Berkeley Lights to Present on Cell Line Development of Complex Molecules and Accelerating Antibody Discovery Against Difficult Targets at 13th Annual PEGS Europe
11/1/2021
Berkeley Lights, Inc., a leader in digital cell biology, announced its participation at the 13th Annual PEGS Europe: Protein & Antibody Engineering Summit, being held virtually and in person from November 2-4, 2021, in Barcelona, Spain.
-
Genovac Purchases Third Beacon® Optofluidic System and Expands its Capabilities into Cell Line Development
10/5/2021
Berkeley Lights, Inc. announced Genovac’s expansion into cell line development capabilities using the Berkeley Lights Beacon® system and Opto™ CLD workflow.
-
Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia to the Board of Directors
9/9/2021
Berkeley Lights, Inc., a leader in digital cell biology, announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021.
-
Berkeley Lights Reports Second Quarter 2021 Financial Results
8/11/2021
Berkeley Lights, Inc., a leader in Digital Cell Biology, reported financial results for the quarter ended June 30, 2021.
-
Berkeley Lights and Bayer announce a multi-year agreement aimed at revolutionizing the discovery of next-generation traits
8/11/2021
Berkeley Lights, Inc. a leader in the functional characterization of live biology, announced a multi-year agreement with Bayer to develop and perform high-throughput functional screening workflows aimed at accelerating and expanding the discovery of novel traits.
-
Berkeley Lights to Report Second Quarter 2021 Financial Results on August 11, 2021
7/13/2021
Berkeley Lights, Inc. today announced the company will be reporting financial results for the second quarter 2021 before market open on Wednesday, August 11, 2021.
-
Berkeley Lights releases subscription-based access program and signs first customers
6/1/2021
Berkeley Lights, Inc., a leader in digital cell biology, announced the release of its TechAccess Subscription model to enable broader customer access to their cutting-edge, single-cell screening technology.
-
Berkeley Lights to Participate in the William Blair 41st Annual Growth Stock Conference
5/20/2021
- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating virtually in the upcoming William Blair 41 st Annual Growth Stock Conference. Berkeley Lights’ management is scheduled to participate in a fireside chat on Tuesday, June 1 at 10:40 a.m. Pacific Time / 1:40 p.m. Eastern Time.
-
Berkeley Lights Reports First Quarter 2021 Financial ResultsQ1 2021 revenue increased 35% year over year
5/11/2021
Berkeley Lights, Inc., a leader in Digital Cell Biology, reported financial results for the quarter ended March 31, 2021.
-
Berkeley Lights Announces Changes to Board of Directors
5/11/2021
Gregory T. Lucier named Board Chairperson, succeeding Michael Marks John Chiminski joins Board as an Independent Director EMERYVILLE, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Gregory T. Lucier has been named Chairperson of the Board of Directors, effective May 14, 2021. He will succeed Michael Marks, who is retiring from the Board. Concurrent with this appointment, John Chiminski, chief executive